Laura L. Johnson - Aug 30, 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Director
Signature
/s/ Laura L. Johnson
Stock symbol
KTRA
Transactions as of
Aug 30, 2023
Transactions value $
$0
Form type
4
Date filed
9/1/2023, 06:00 PM
Previous filing
Aug 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +8.5K $0.00 8.5K Aug 30, 2023 Common Stock 8.5K $4.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on September 30, 2023.